100 related articles for article (PubMed ID: 22531482)
1. The purple toe syndrome in female with Factor V Leiden mutation successfully treated with enoxaparin.
Dulíček P; Bártová J; Beránek M; Malý J; Pecka M
Clin Appl Thromb Hemost; 2013; 19(1):100-2. PubMed ID: 22531482
[TBL] [Abstract][Full Text] [Related]
2. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
Mooney T; Joseph P
Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
[No Abstract] [Full Text] [Related]
3. Late onset purple toe syndrome with warfarin successfully treated with fondaparinux.
Rindone JP; Mellen CK; Eliason JD
Am J Ther; 2011 Nov; 18(6):e277-9. PubMed ID: 20535004
[TBL] [Abstract][Full Text] [Related]
4. Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome.
Talmadge DB; Spyropoulos AC
Pharmacotherapy; 2003 May; 23(5):674-7. PubMed ID: 12741443
[TBL] [Abstract][Full Text] [Related]
5. Invited commentary.
Henke PK
J Vasc Surg; 2010 Nov; 52(5):1270-1. PubMed ID: 21050988
[No Abstract] [Full Text] [Related]
6. [Venous thromboembolism prophylaxis after total hip arthroplasty].
Kučera T; Malý R; Urban K; Sponer P
Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol emboli associated with warfarin treatment.
Moll S; Huffman J
Am J Hematol; 2004 Oct; 77(2):194-5. PubMed ID: 15389900
[No Abstract] [Full Text] [Related]
8. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
9. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
Enyart JJ; Jones RJ
Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
[TBL] [Abstract][Full Text] [Related]
10. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
[TBL] [Abstract][Full Text] [Related]
11. Unusual side effects due to warfarin.
Krahn MJ; Pettigrew NM; Cuddy TE
Can J Cardiol; 1998 Jan; 14(1):90-3. PubMed ID: 9487280
[TBL] [Abstract][Full Text] [Related]
12. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin.
McLintock C; McCowan LM; North RA
BJOG; 2009 Nov; 116(12):1585-92. PubMed ID: 19681850
[TBL] [Abstract][Full Text] [Related]
13. [Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins].
Vorob'eva NM; Panchenko EP; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Postnov AIu; Kirienko AI
Ter Arkh; 2011; 83(8):33-7. PubMed ID: 21961329
[TBL] [Abstract][Full Text] [Related]
14. Warfarin-related purple toes syndrome and cholesterol microembolization.
Hyman BT; Landas SK; Ashman RF; Schelper RL; Robinson RA
Am J Med; 1987 Jun; 82(6):1233-7. PubMed ID: 3605140
[TBL] [Abstract][Full Text] [Related]
15. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
16. Anaphylaxis with tissue plasminogen activator: case report and literature review.
Patel M; Rumore MM
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):568-70. PubMed ID: 22874743
[No Abstract] [Full Text] [Related]
17. Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study.
Hacobian M; Shetty R; Niles CM; Gerhard-Herman M; Vallurupalli N; Baroletti S; McKean SC; Sonis J; Parasuraman S; Kosowsky JM; Goldhaber SZ
Clin Appl Thromb Hemost; 2010 Feb; 16(1):21-5. PubMed ID: 19147527
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Pauzner R; Dulitzki M; Langevitz P; Livneh A; Kenett R; Many A
Thromb Haemost; 2001 Dec; 86(6):1379-84. PubMed ID: 11776303
[TBL] [Abstract][Full Text] [Related]
19. [Acute coronary syndrome in patients using acetylsalicylic acid or warfarin].
Vik-Mo H; Hegbom K
Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1105-6. PubMed ID: 15114389
[No Abstract] [Full Text] [Related]
20. A case of unilateral purple toes due to warfarin.
Al-Niaimi F; Clark C
Clin Exp Dermatol; 2009 Jun; 34(4):527-8. PubMed ID: 19196305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
